Annual Cash & Cash Equivalents
$36.12 M
-$5.30 M-12.81%
September 30, 2024
Summary
- As of February 7, 2025, SRDX annual cash & cash equivalents is $36.12 million, with the most recent change of -$5.30 million (-12.81%) on September 30, 2024.
- During the last 3 years, SRDX annual cash & cash equivalents has risen by +$4.96 million (+15.93%).
- SRDX annual cash & cash equivalents is now -35.03% below its all-time high of $55.59 million, reached on September 30, 2015.
Performance
SRDX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$30.14 M
-$5.97 M-16.53%
December 31, 2024
Summary
- As of February 7, 2025, SRDX quarterly cash and cash equivalents is $30.14 million, with the most recent change of -$5.97 million (-16.53%) on December 31, 2024.
- Over the past year, SRDX quarterly cash and cash equivalents has increased by +$6.79 million (+29.07%).
- SRDX quarterly cash and cash equivalents is now -54.23% below its all-time high of $65.87 million, reached on June 30, 2012.
Performance
SRDX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SRDX Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.8% | +29.1% |
3 y3 years | +15.9% | +29.1% |
5 y5 years | +18.9% | +29.1% |
SRDX Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -12.8% | +90.1% | -32.4% | +58.7% |
5 y | 5-year | -12.8% | +90.1% | -51.5% | +234.7% |
alltime | all time | -35.0% | +2678.1% | -54.2% | >+9999.0% |
Surmodics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $30.14 M(-16.5%) |
Sep 2024 | $36.12 M(-12.8%) | $36.12 M(+48.6%) |
Jun 2024 | - | $24.30 M(-26.4%) |
Mar 2024 | - | $33.03 M(+41.4%) |
Dec 2023 | - | $23.36 M(-43.6%) |
Sep 2023 | $41.42 M(+118.0%) | $41.42 M(-7.1%) |
Jun 2023 | - | $44.58 M(+132.4%) |
Mar 2023 | - | $19.18 M(-27.4%) |
Dec 2022 | - | $26.43 M(+39.1%) |
Sep 2022 | $19.00 M(-39.0%) | $19.00 M(-5.4%) |
Jun 2022 | - | $20.07 M(-18.8%) |
Mar 2022 | - | $24.71 M(-7.3%) |
Dec 2021 | - | $26.65 M(-14.5%) |
Sep 2021 | $31.15 M(+1.2%) | $31.15 M(-49.9%) |
Jun 2021 | - | $62.18 M(+29.1%) |
Mar 2021 | - | $48.16 M(+34.7%) |
Dec 2020 | - | $35.75 M(+16.1%) |
Sep 2020 | $30.79 M(+1.4%) | $30.79 M(-15.4%) |
Jun 2020 | - | $36.39 M(+139.3%) |
Mar 2020 | - | $15.21 M(+68.9%) |
Dec 2019 | - | $9.01 M(-70.3%) |
Sep 2019 | $30.36 M(+30.2%) | $30.36 M(+5.0%) |
Jun 2019 | - | $28.92 M(+28.7%) |
Mar 2019 | - | $22.47 M(+56.0%) |
Dec 2018 | - | $14.40 M(-38.2%) |
Sep 2018 | $23.32 M(+41.0%) | $23.32 M(-14.5%) |
Jun 2018 | - | $27.27 M(-1.6%) |
Mar 2018 | - | $27.71 M(+28.3%) |
Dec 2017 | - | $21.60 M(+30.6%) |
Sep 2017 | $16.53 M(-33.8%) | $16.53 M(+45.7%) |
Jun 2017 | - | $11.35 M(+0.8%) |
Mar 2017 | - | $11.26 M(-36.2%) |
Dec 2016 | - | $17.65 M(-29.4%) |
Sep 2016 | $24.99 M(-55.0%) | $24.99 M(-27.9%) |
Jun 2016 | - | $34.66 M(-11.1%) |
Mar 2016 | - | $38.99 M(-8.6%) |
Dec 2015 | - | $42.67 M(-23.2%) |
Sep 2015 | $55.59 M(+27.8%) | $55.59 M(+2.7%) |
Jun 2015 | - | $54.11 M(+80.3%) |
Mar 2015 | - | $30.02 M(+13.0%) |
Dec 2014 | - | $26.56 M(-39.0%) |
Sep 2014 | $43.51 M(+180.8%) | $43.51 M(+9.5%) |
Jun 2014 | - | $39.73 M(+370.5%) |
Mar 2014 | - | $8.44 M(-19.7%) |
Dec 2013 | - | $10.52 M(-32.1%) |
Sep 2013 | $15.49 M(-0.3%) | $15.49 M(-12.5%) |
Jun 2013 | - | $17.71 M(-13.8%) |
Mar 2013 | - | $20.54 M(-4.3%) |
Dec 2012 | - | $21.46 M(+38.1%) |
Sep 2012 | $15.54 M(-33.1%) | $15.54 M(-76.4%) |
Jun 2012 | - | $65.87 M(+9.4%) |
Mar 2012 | - | $60.18 M(+21.9%) |
Dec 2011 | - | $49.36 M(+112.6%) |
Sep 2011 | $23.22 M | $23.22 M(+25.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | $18.44 M(+19.0%) |
Mar 2011 | - | $15.49 M(+8.3%) |
Dec 2010 | - | $14.31 M(+25.6%) |
Sep 2010 | $11.39 M(-2.1%) | $11.39 M(+32.2%) |
Jun 2010 | - | $8.62 M(-22.9%) |
Mar 2010 | - | $11.17 M(+0.4%) |
Dec 2009 | - | $11.13 M(-4.4%) |
Sep 2009 | $11.64 M(-24.3%) | $11.64 M(+102.6%) |
Jun 2009 | - | $5.74 M(+3.8%) |
Mar 2009 | - | $5.53 M(-53.8%) |
Dec 2008 | - | $11.97 M(-22.2%) |
Sep 2008 | $15.38 M(+11.3%) | $15.38 M(+12.6%) |
Jun 2008 | - | $13.66 M(-48.9%) |
Mar 2008 | - | $26.75 M(+78.3%) |
Dec 2007 | - | $15.00 M(+8.6%) |
Sep 2007 | $13.81 M(+268.2%) | $13.81 M(+248.8%) |
Jun 2007 | - | $3.96 M(-34.2%) |
Mar 2007 | - | $6.02 M(+2484.5%) |
Dec 2006 | - | $233.00 K(-93.8%) |
Sep 2006 | $3.75 M(-4.3%) | $3.75 M(+100.6%) |
Jun 2006 | - | $1.87 M(+18.4%) |
Mar 2006 | - | $1.58 M(-12.4%) |
Dec 2005 | - | $1.80 M(-54.0%) |
Sep 2005 | $3.92 M(+44.7%) | $3.92 M(-21.3%) |
Jun 2005 | - | $4.98 M(+411.4%) |
Mar 2005 | - | $974.00 K(-52.6%) |
Dec 2004 | - | $2.06 M(-24.1%) |
Sep 2004 | $2.71 M(-32.4%) | $2.71 M(-78.2%) |
Jun 2004 | - | $12.43 M(+91.5%) |
Mar 2004 | - | $6.49 M(-18.5%) |
Dec 2003 | - | $7.96 M(+98.8%) |
Sep 2003 | $4.01 M(-56.5%) | $4.01 M(-23.8%) |
Jun 2003 | - | $5.26 M(-0.0%) |
Mar 2003 | - | $5.26 M(-49.0%) |
Dec 2002 | - | $10.32 M(+12.1%) |
Sep 2002 | $9.21 M(+1.8%) | $9.21 M(+44.0%) |
Jun 2002 | - | $6.39 M(+68.7%) |
Mar 2002 | - | $3.79 M(+86.2%) |
Dec 2001 | - | $2.04 M(-77.5%) |
Sep 2001 | $9.04 M(+498.9%) | $9.04 M(+93.0%) |
Jun 2001 | - | $4.69 M(+13.1%) |
Mar 2001 | - | $4.14 M(+183.6%) |
Dec 2000 | - | $1.46 M(-3.2%) |
Sep 2000 | $1.51 M(-24.5%) | $1.51 M(+13.9%) |
Jun 2000 | - | $1.33 M(-49.8%) |
Mar 2000 | - | $2.64 M(+46.7%) |
Dec 1999 | - | $1.80 M(-10.0%) |
Sep 1999 | $2.00 M(+53.8%) | $2.00 M(+81.8%) |
Jun 1999 | - | $1.10 M(-8.3%) |
Mar 1999 | - | $1.20 M(+20.0%) |
Dec 1998 | - | $1.00 M(-23.1%) |
Sep 1998 | $1.30 M | $1.30 M(-27.8%) |
Jun 1998 | - | $1.80 M(-89.5%) |
Mar 1998 | - | $17.10 M |
FAQ
- What is Surmodics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Surmodics?
- What is Surmodics annual cash & cash equivalents year-on-year change?
- What is Surmodics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Surmodics?
- What is Surmodics quarterly cash and cash equivalents year-on-year change?
What is Surmodics annual cash & cash equivalents?
The current annual cash & cash equivalents of SRDX is $36.12 M
What is the all time high annual cash & cash equivalents for Surmodics?
Surmodics all-time high annual cash & cash equivalents is $55.59 M
What is Surmodics annual cash & cash equivalents year-on-year change?
Over the past year, SRDX annual cash & cash equivalents has changed by -$5.30 M (-12.81%)
What is Surmodics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SRDX is $30.14 M
What is the all time high quarterly cash and cash equivalents for Surmodics?
Surmodics all-time high quarterly cash and cash equivalents is $65.87 M
What is Surmodics quarterly cash and cash equivalents year-on-year change?
Over the past year, SRDX quarterly cash and cash equivalents has changed by +$6.79 M (+29.07%)